Just read this in the quarterly of another small Aussie biotech
“XXXX announced an on-market share buyback for up to 4 million XXXX Oncology ordinary shares over the next 12 months (ASX announcement: 9 June 2022). The on-market buyback allows the company to take advantage of share price volatility through opportunistic share purchases during periods when the share price does not reflect the robust outlook for the company.“
Hmmm….wonder if our management thought of doing this…nah, not a hope in hell!
something has to give.....the share price is absolutely ridiculous, page-10
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
